Gyre Therapeutics Inc. (GYRE) earnings · rev $116.6M
These earnings events as JSON? API free 100/dayGyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
This GYRE earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported GYRE revenue for 2025-12-31 was $116.6M. Net income was $9.9M. Revenue was up 10.2% from 2024-12-31 to 2025-12-31. GYRE currently screens at market cap $589.9M.
When the next GYRE 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 10.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full GYRE research stays on the stock page; the tape stays on the quote page.
GYRE earnings FAQ
What are GYRE's latest revenue and net income?
Latest cached Gyre Therapeutics Inc. (GYRE) revenue for Dec 31, 2025 was $116.6M. Net income was $9.9M. Statements: https://lician.com/financials/gyre
What is GYRE's latest diluted EPS?
Latest cached Gyre Therapeutics Inc. (GYRE) diluted EPS for Dec 31, 2025 was $0.02.
What period does the latest GYRE earnings print cover?
The latest cached Gyre Therapeutics Inc. (GYRE) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did GYRE revenue change from the prior cached period?
Cached Gyre Therapeutics Inc. (GYRE) revenue was up 10.2% from $105.8M (Dec 31, 2024) to $116.6M (Dec 31, 2025). Statements: https://lician.com/financials/gyre
Where are GYRE earnings listed?
Cached earnings facts for Gyre Therapeutics Inc. (GYRE) are listed at https://lician.com/earnings/gyre. Statements: https://lician.com/financials/gyre
Not investment advice.